SCHEMBL19732886

SCHEMBL19732886

CCCCCCCC(=O)C(C)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.57
GPR84 Q9NQS5 6/20 0.54
PPARG P37231 6/20 0.54
PPARD Q03181 6/20 0.54
PPARA Q07869 6/20 0.54
HDAC11 Q96DB2 5/20 0.54
TSHR P16473 4/20 0.54
ALDH1A1 P00352 2/20 0.54
TLR2 O60603 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
FABP4 P15090 2/20 0.54
PTPN1 P18031 2/20 0.54
SLC22A6 Q4U2R8 1/20 0.54
SLC22A8 Q8TCC7 1/20 0.54
MEN1 O00255 1/20 0.54
ESR1 P03372 1/20 0.54
ALOX15 P16050 1/20 0.54
PDE4A P27815 1/20 0.54
KMT2A Q03164 1/20 0.54
PDE3A Q14432 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8637203 1.00 CES2 (0.57) CES2GPR84PPARGPPARDPPARA
SCHEMBL28823312 1.00 CES2 (0.57) CES2GPR84PPARGPPARDPPARA
SCHEMBL18528772 1.00 CES2 (0.57) CES2GPR84PPARGPPARDPPARA
SCHEMBL8780156 1.00 CES2 (0.57) CES2GPR84PPARGPPARDPPARA
SCHEMBL28923381 1.00 CES2 (0.57) CES2GPR84PPARGPPARDPPARA
SCHEMBL10360944 1.00 CES2 (0.57) CES2GPR84PPARGPPARDPPARA
Ammonia Solution, Strong SCHEMBL27577496 0.98 CES2 (0.55) CES2GPR84PPARGPPARDPPARA
SCHEMBL3142041 0.98 CES2 (0.54) CES2GPR84PPARGPPARDPPARA
SCHEMBL2411791 0.91 CES2 (0.46) CES2ALDH1A1MEN1KMT2A
SCHEMBL5528500 0.91 CES2 (0.46) CES2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11596626-B2 Compound for use against pathogenic Neisseria and Haemophilus species and Moraxella catarrhalis Universität Konstanz (DE) 2023-03-07 US disclosed
EP-3475260-B1 COMPOUNDS FOR USE AS AN ANTI-BACTERIAL OR ANTI-FUNGAL AGENT AND AS A ZINC SENSOR UNIV KONSTANZ (DE) 2022-03-30 EP disclosed
US-20210169869-A1 Compound for Use Against Pathogenic Neisseria and Haemophilus Species and Moraxella Catarrhalis Universität Wien (AT) 2021-06-10 US disclosed
US-10961196-B2 Compounds for use as an anti-bacterial or anti-fungal agent and as a zinc sensor Universität Konstanz (DE) 2021-03-30 US disclosed
EP-3728193-A1 COMPOUND FOR USE AGAINST PATHOGENIC NEISSERIA AND HAEMOPHILUS SPECIES AND MORAXELLA CATARRHALIS Universität Konstanz (DE) 2020-10-28 EP disclosed
US-20190218183-A1 COMPOUNDS FOR USE AS AN ANTI-BACTERIAL OR ANTI-FUNGAL AGENT AND AS A ZINC SENSOR Universität Konstanz (DE) 2019-07-18 US disclosed
EP-3502095-A1 COMPOUND FOR USE AGAINST PATHOGENIC NEISSERIA AND HAEMOPHILUS SPECIES AND MORAXELLA CATARRHALIS Universität Konstanz (DE) 2019-06-26 EP disclosed
EP-3475260-A1 COMPOUNDS FOR USE AS AN ANTI-BACTERIAL OR ANTI-FUNGAL AGENT AND AS A ZINC SENSOR Universität Konstanz (DE) 2019-05-01 EP disclosed
WO-2017220205-A1 COMPOUNDS FOR USE AS AN ANTI-BACTERIAL OR ANTI-FUNGAL AGENT AND AS A ZINC SENSOR Universität Konstanz (DE) 2017-12-28 WO disclosed
EP-3260445-A1 COMPOUNDS FOR USE AS AN ANTI-BACTERIAL OR ANTI-FUNGAL AGENT AND AS A ZINC SENSOR Universität Konstanz (DE) 2017-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11596626-B2 Compound for use against pathogenic Neisseria and Haemophilus species and Moraxella catarrhalis MLEC, MPO, B3GNT2 CES2 3410/4885GPR84 2107/4885PPARG 1344/4885
US-20190218183-A1 COMPOUNDS FOR USE AS AN ANTI-BACTERIAL OR ANTI-FUNGAL AGENT AND AS A ZINC SENSOR ZFR, ZC3HAV1, ZFX CES2 4210/4885GPR84 1225/4885PPARG 2261/4885
US-10961196-B2 Compounds for use as an anti-bacterial or anti-fungal agent and as a zinc sensor ZFR, ZC3HAV1, ZFX CES2 4210/4885GPR84 1225/4885PPARG 2261/4885
US-20210169869-A1 Compound for Use Against Pathogenic Neisseria and Haemophilus Species and Moraxella Catarrhalis MLEC, MPO, B3GNT2 CES2 3410/4885GPR84 2107/4885PPARG 1344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.